Loading organizations...

§ Private Profile · Rishon Le Zion, HaMerkaz, Israel
Israeli medical device company developing solutions for obstructive sleep apnea (OSA) treatment, focused on keePAP wearable APAP device.
keepMED is an Israeli medical device company developing innovative solutions for obstructive sleep apnea (OSA) treatment. The company focuses on creating more comfortable and compliant alternatives to traditional continuous positive airway pressure (CPAP) machines, which often involve masks and air blowers. Its flagship product, the keePAP™ device, is a small, wearable, non-continuous automatic positive airway pressure system designed to improve patient experience and adherence. keepMED operates as a venture capital-funded entity, having completed at least a Series C financing round to support the regulatory clearance of its keePAP device. Alex Rapoport serves as the company's CEO, guiding its efforts in the medical device sector, primarily targeting OSA patients seeking advanced treatment options. The company was founded in 2012. Its business model centers on venture capital funded, the company has completed at least a Series C financing round as of available records.
keepMED has raised $25.2M across 2 funding rounds.
keepMED has raised $25.2M in total across 2 funding rounds.
keepMED has raised $25.2M in total across 2 funding rounds.
keepMED's investors include 4See Ventures, C4 Ventures, Celeste Management, Financière Arbevel, Lavorel Medicare, Valerie Calenda, Pitango Venture Capital, Xenia Venture Capital, David Israeli.
keepMED has raised $25.2M across 2 funding rounds. Most recently, it raised $15.2M Series C in September 2020.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Sep 29, 2020 | $15.2M Series C | — | 4See Ventures, C4 Ventures, Celeste Management, Financière Arbevel, Lavorel Medicare, Valerie Calenda, Pitango Venture Capital, Xenia Venture Capital | Announced |
| Apr 29, 2015 | $10M Series B | Valerie Calenda, David Israeli | Xenia Venture Capital | Announced |